Electra Therapeutics, Inc.
ETRA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002088082
In the last 90 days, Electra Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of ETRA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Electra Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 13D | 11.00%6.89M shares | New | Sep 25, 20261 filing | Sep 25, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Electra Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 25, 20265:11 PM ET | OrbiMed Advisors LLCand 2 others | 13D | 11.00%6.89M shares | New | Sep 21, 2026 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Electra Therapeutics, Inc. shares.
No Form 144 notices for Electra Therapeutics, Inc. are on file.